Lamivudine: a new strategy to suppress HBV replication in the pretransplant setting.
Macedo
G
G
Gastroenterology and Liver Transplant Units, H.S. João, Porto, Portugal.
Maia
J C
JC
Gomes
A
A
Beleza
M
M
Teixeira
A
A
Ribeiro
A
A
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D006509:Hepatitis B / Q000175:diagnosis / Q000517:prevention & control*; D006515:Hepatitis B virus / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D016031:Liver Transplantation; D008875:Middle Aged; D011292:Premedication; D012008:Recurrence; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D019259:Lamivudine